-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
-
Summary
-
BridgeBio Pharma, Inc. quarterly Accounts Payable, Current history and growth rate from Q4 2018 to Q4 2024.
- BridgeBio Pharma, Inc. Accounts Payable, Current for the quarter ending December 31, 2024 was $9.62M, a 9.73% decline year-over-year.
Accounts Payable, Current, Quarterly (USD)
Accounts Payable, Current, YoY Quarterly Growth (%)